MR. JAMES THOMAS POTTER M.D. NPI 1437286853

NPI Details

MR. James Thomas Potter, M.D. is an adolescent medicine pediatrics in Norton, VA with 26 years of experience. The provider is a pediatrician who specializes in adolescent medicine is a multi-disciplinary healthcare specialist trained in the unique physical, psychological and social characteristics of adolescents, their healthcare problems and needs. MR. James Thomas Potter, M.D. NPI is 1437286853. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: EAST TENNESSEE STATE UNIVERSITY QUILLEN COLLEGE OF MEDICINE
Graduation Year:2000

The provider's business location address is:

611 TRENT ST NE STE A
NORTON, VA
ZIP 24273-533
Phone: (276) 679-5437
Fax: (276) 679-5438

The NPI 1437286853 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Test for allergy using allergenic extract (HCPCS:95004)
• Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
• Professional service for multiple injections of allergen (HCPCS:95117)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Removal of impacted ear wax (HCPCS:69210)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)

The enumeration date for this NPI number is 2/27/2007 and was last updated on 3/26/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.